Evidence map›Paper›PMID 39531505›Full record

ArticleDiabetes2025

Type 1 Diabetes Genetic Risk Contributes to Phenotypic Presentation in Monogenic Autoimmune Diabetes.

Amber M Luckett, Gareth Hawkes, Harry D Green, Elisa De Franco, William A Hagopian, Bart O Roep, Michael N Weedon, Richard A Oram, Matthew B Johnson, EXE-T1D consortium

Abstract read
In one paragraph

Article in Diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genetic risk in extremely early onset type 1 diabetes.medRxiv : the preprint server for health sciences · 2025
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amber M LuckettDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0001-9496-3796
Gareth HawkesDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0002-3367-789X
Harry D GreenDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0002-5105-184X
Elisa De FrancoDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0002-1437-7891
William A HagopianDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.ORCID 0000-0003-2979-0475
Bart O RoepDepartment of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Michael N WeedonDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0002-6174-6135
Richard A OramDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0003-3581-8980
Matthew B JohnsonDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, U.K.ORCID 0000-0002-6519-6687
EXE-T1D consortium

Funding

Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)U01DK128847 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · 2021 to 2026
$79.2M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Diabetes UK Harry Keen FellowshipEuropean Foundation for the Study of Diabetes Foundation Future Leaders AwardJuvenile Diabetes Research Foundation International RD Lawrence FellowshipJuvenile Diabetes Research Foundation United Kingdom RD Lawrence FellowshipMedical Research Council Confidence in Concept grantNIDDK NIH HHS 5U01DK128847NIDDK NIH HHS P30 DK017047NIDDK NIH HHS U01 DK128847Novo Nordisk Foundation Future Leaders AwardRandox R&D PhD Studentship
6 · The paper itself

Abstract

article highlightsThere is variability in early-onset autoimmune diabetes presentation in individuals with monogenic autoimmunity; the mechanism(s) underlying this is unclear. We examined whether type 1 diabetes (T1D) polygenic risk contributes to clinical phenotype in monogenic autoimmune diabetes. Individuals with monogenic autoimmune diabetes had higher T1D genetic risk scores compared with control cohorts, driven largely by increased presence of T1D-risk DR3-DQ2 haplotype. Established T1D polygenic risk alleles, particularly class II HLA genes, contribute to clinical presentation in monogenic autoimmunity.

Indexed as

Diabetes Mellitus, Type 1Genetic Predisposition to DiseaseAdolescentAdultAutoimmunityChildFemaleHaplotypesHLA-DQ AntigensHLA-DR3 AntigenHumansMaleMultifactorial InheritancePhenotypeHLA-DQ2 antigenHLA-DQ AntigensHLA-DR3 Antigen

Identifiers

PMID39531505
PMCPMC11755682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.